Colistimethate (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Colistimethate drug offered from Fresenius Kabi USA, LLC. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | COLISTIMETHATE SODIUM |
SUBSTANCE NAME: | COLISTIMETHATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-12-04 |
END MARKETING DATE: | 0000-00-00 |
Colistimethate HUMAN PRESCRIPTION DRUG Details:
Item Description | Colistimethate from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/2mL) |
START MARKETING DATE: | 2009-12-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-393_40ae8d43-e65a-4533-bb94-babdac91d4b8 |
PRODUCT NDC: | 63323-393 |
APPLICATION NUMBER: | ANDA065364 |
Other COLISTIMETHATE SODIUM Pharmaceutical Manufacturers / Labelers: